Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide

Led by Osage Venture Partners, Debiopharm, HearstLab, and Golden Seeds

SAN FRANCISCO, CA -- Strategikon, provider of cloud-based solutions that optimize and accelerate the budgeting, planning, outsourcing, and vendor management of clinical trials, has recently closed an over-subscribed $7.0M Series A1 financing round. This achievement underscores the high demand and investor confidence in Strategikon's pioneering technolog…